Durata Therapeutics (DRTX) Sees IPO Price of $11 - $13/Share

Durata Therapeutics (Nasdaq: DRTX) filed an amended registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The Company plans to offer 6,250,000 shares of Common Stock and sees an offering price of $11 to $13 per share. Durata plans to list on the Nasdaq Global Market under the ticker, "DRTX."

The offering is being made through BofA Merrill Lynch, Credit Suisse, RBC Capital Markets, and Wedbush PacGrow Life Sciences.

Durata Therapeutics is a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Target registers 15.5 million additional shares for employee incentive plan
• BioLineRx plans $3.75M share offering at $2.78 per ADS
• Zentek shares to move from Nasdaq to OTC Markets on Sept. 2